| Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes. | |
| | |
MedLine Citation:
|
PMID: 22214489 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Introduction: Although traditionally used as a final treatment option, early use of insulin is a therapeutic option after metformin failure in type 2 diabetes. Injection of native insulin lacks the rapid onset of action after food ingestion and the chronic maintenance of a steady-state low-level basal insulin in fasting periods. These limitations have fuelled the development of insulin analogues, which mainly fall into two different categories: short-acting and long-acting analogues. Areas covered: We review the recent literature investigating the efficacy and safety of insulin analogues in human diabetes, with emphasis on type 2 diabetes, as about 30% of these patients are being treated with insulin. We also examine novel developments in this area, including the new long-acting basal analogues whose longer duration of action might reduce dosing frequency to three times a week. Expert opinion: Insulin analogues show some advantage compared with native insulin. However, improvements in reducing their pharmacological variability would be expected to lower the risk of hypoglycemia and hyperglycemia, as well as to simplify and perhaps also encourage optimal insulin titration in real-life clinical practice. Extending the duration of insulin effect would also allow for greater flexibility and potentially reduce the frequency of blood glucose monitoring. |
| | |
Authors:
|
Katherine Esposito; Dario Giugliano |
Related Documents
:
|
14753979 - Pulsar recoil by large-scale anisotropies in supernova explosions. 21842289 - Surgical treatment of type 2 diabetes: the surgeon perspective. 22043209 - Choosing a revascularization strategy in patients with diabetes and stable coronary art... 1867409 - Changes of glycoconjugate contents of the zona pellucida during oocyte growth and devel... 21668339 - Overall mortality in diabetes mellitus: where do we stand today? 21088829 - Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 dia... 7656919 - Dopaminergic and cholinergic control of arginine-vasopressin secretion in type i diabet... 10604109 - Evolving concepts in the pathophysiology of biliary lipid secretion. 1147159 - Neurogenic disorders of the foot in diabetes mellitus. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-4 |
Journal Detail:
|
Title: Expert opinion on biological therapy Volume: - ISSN: 1744-7682 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-4 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101125414 Medline TA: Expert Opin Biol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Second University of Naples, Department of Cardio-Thoracic and Respiratory Sciences , Piazza Miraglia 2, 80138, Naples , Italy +39 081 5665045 ; +39 081 5665045 ; katherine.esposito@unina2.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bioactivity-based screening methods for antibiotics residues: a comparative study of commercial and ...
Next Document: Anisotropic Third-Order Optical Nonlinearity of a single ZnO Micro/Nano-wire.